Frontiers in Precision Medicine – Exploring Science and Policy Boundaries

There are two locations for this event: Thursday, December 3, 2015, EIHG Auditorium, University of Utah Friday, December 4, 2015, S.J. Quinney College of Law Moot Courtroom (Level 6) Sponsored by the S.J. Quinney College of Law Center for Law and Biomedical Sciences, the University of Utah School of Medicine and the Huntsman Cancer Institute […]

The Slippery Slope of Hobby Lobby Already at the Supreme Court’s Door

  By Kendra Brown for The United States Supreme Court has agreed to hear another challenge to the Affordable Care Act’s (ACA) preventive care mandate.[1] The ACA requires that employers through their healthcare plans provide at no cost the full range of FDA-approved contraceptives. In Burwell v. Hobby Lobby,[2] a closely held for profit […]

There Will Be Blood

By Kylie Orme for Several weeks ago, Judge Wiggins, a circuit court judge in Marion, Alabama, sparked controversy when he told a courtroom full of offenders that if they did not have the money to pay their fines, they could go outside of the courtroom and donate blood, or go to jail. In an […]

The Price of Health Privacy in Sports

By Travis Walker for  Part of the digital age is access to information. For sports fans this includes updates on players and strategy that is nearly instantaneous. Media leaders make it possible to know everything about a game – creating a want, if not an expectation. Despite the numerous updates given daily, a single […]

When is a Covenant just a Covenant? Of Meso, Newman and Transactions with Patents

Originally posted on New Private Law blog by Jorge Contreras. A petition for certiorari was recently filed with the Supreme Court in Meso Scale Diagnostics LLC v. Roche Diagnostics GmbH (Del. 2015). In it, Petitioner poses the following question: “Whether a covenant, promise, or agreement not to sue for the infringement of a federal patent is a license of that patent as […]

Patent Trolls and the “Presumption of Validity”

By Dave Duncan for Should the “presumption of validity” regarding issued patents be reversed? A patent application goes through an extensive examination process at the United States Patent and Trademark Office (“USPTO”). If and when the applied-for patent is issued, it is presumed to be valid in subsequent legal challenges unless it can be […]

Abilify’s Adherence Sensor: Thoughts to Consider in the Regulatory Process

By Anikka Hoidal for Abilify is a medication frequently used to treat schizophrenia and bipolar disorder. Japan-based Otsuka Pharmaceutical Company developed the drug. Otsuka has teamed up with Proteus Health to use its sensor technology, which can provide notification that a pill has been ingested. The sensor works in combination with a patch patients wear […]

Federal Circuit Rules Against the University of Utah in Joint Inventorship Case

By Austen Paulsen, Class of 2016, for In a battle over the inventorship of a group of patents known as “the Tuschl-II Patents,” Judge Saris of the District Court for the District of Massachusetts recently ruled against the University of Utah (“the University”). In 2011, the University sued Max-Planck-Gesellschaft Zur Föerderung Der Wissenschaften e.V. […]

ACA Subsidies Live On

ACA subsidies live on – King v. Burwell Decision surprisingly does not turn on Chevron analysis but predicted to still have a strong impact on statutory interpretation going forward By Micah Vorwaller, Class of 2015, for   This article discusses the recent decision by the Supreme Court in King v. Burwell[1] that allowed tax subsidies […]

Turing Backs Down in the Face of Social Media Pressure, Not Law

By Teneille Brown for Teneille Brown is a professor of law and adjunct professor of Internal Medicine at the University of Utah.  Social media feeds were ablaze last week when it was revealed that Turing Pharmaceuticals raised the price of a life-saving toxoplasmosis drug, Daraprim, from $13.50 per tablet to $750 per tablet. Twitter […]